1 The Neurology Department, Texas Scottish Rite Hospital For Children, Dallas; University Of Texas Southwestern Medical Center, Dallas.
2 The Neurology Department, Texas Scottish Rite Hospital For Children, Dallas.
3 University Of Texas Southwestern Medical Center, Dallas.
Objective. The risk of seizure relapse after antiepileptic drug (AED) discontinuation in children has been reported to vary between 6% and 40%. It has been suggested that neurologic deficit and mental retardation are poor prognostic factors for seizure relapse after AED discontinuation. Because epileptic children with cerebral palsy (CP) have neurologic deficits, and many have mental retardation, it is important to know their risk for seizure relapse.
Methods. AED treatment was discontinued in 65 children with CP and histories of epilepsy after 2 seizure-free years. All of the patients were followed until they had seizure relapses or for at least 2 years without seizures after AEDs were stopped. Multiple factors were analyzed for possible association with seizure relapse.
Results. Twenty-seven patients (41.5%) had seizure relapses. Patients with spastic hemiparesis had the highest relapse rate (61.5%), and those with spastic diplegia had the lowest rate (14.3%). No other factor correlated significantly with the risk of seizure relapse.
Conclusions. Discontinuation of AEDs in children with CP can, and should, be practiced when possible after patients have been seizure-free for at least 2 years. AED discontinuation in patients with spastic hemiparesis is significantly more likely to lead to seizure relapse than in patients with other CP types, but no other factor is yet known to increase the chance of relapse.
Key Words: epilepsy children antiepileptic drugs seizure relapse cerebral palsy
Submitted on October 31, 1994
Accepted on April 7, 1995
This article has been cited by other articles:
![]() |
M. C. Smith Optimizing therapy of seizures in children and adolescents with developmental disabilities Neurology, December 26, 2006; 67(12_suppl_4): S52 - S55. [Abstract] [Full Text] |
||||
![]() |
S. P. Sparagana, M. R. Delgado, L. L. Batchelor, and E. S. Roach Seizure Remission and Antiepileptic Drug Discontinuation in Children With Tuberous Sclerosis Complex Arch Neurol, September 1, 2003; 60(9): 1286 - 1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Singhi, S. Jagirdar, N. Khandelwal, and P. Malhi Epilepsy in Children With Cerebral Palsy J Child Neurol, March 1, 2003; 18(3): 174 - 179. [Abstract] [PDF] |
||||
![]() |
R. S. Greenwood and M. B. Tennison When to Start and Stop Anticonvulsant Therapy in Children Arch Neurol, September 1, 1999; 56(9): 1073 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Zafeiriou, E. E. Kontopoulos, and I. Tsikoulas Characteristics and Prognosis of Epilepsy in Children With Cerebral Palsy J Child Neurol, May 1, 1999; 14(5): 289 - 294. [Abstract] [PDF] |
||||